![Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? | British Journal of Cancer Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.127/MediaObjects/41416_2015_Article_BFbjc2015127_Fig1_HTML.jpg)
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? | British Journal of Cancer
![The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions | Scientific Reports The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-023-29888-z/MediaObjects/41598_2023_29888_Fig1_HTML.png)
The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions | Scientific Reports
![Frontiers | Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques Frontiers | Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques](https://www.frontiersin.org/files/Articles/1095059/fonc-12-1095059-HTML/image_m/fonc-12-1095059-g001.jpg)
Frontiers | Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques
![Frontiers | A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer Frontiers | A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer](https://www.frontiersin.org/files/Articles/1119105/fendo-14-1119105-HTML-r1/image_m/fendo-14-1119105-g001.jpg)
Frontiers | A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer
![POR | Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer POR | Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer](https://www.por-journal.com/files/MyHome%20Article%20Library/1610373/1610373_Thumb_400.jpg)
POR | Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
![A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S096097762101002X-gr1.jpg)
A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect
![Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review](https://www.mdpi.com/cancers/cancers-14-01898/article_deploy/html/images/cancers-14-01898-g001.png)
Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
![Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors](https://www.spandidos-publications.com/article_images/ol/17/1/ol-17-01-0616-g02.jpg)
Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors
![Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores](https://www.mdpi.com/cancers/cancers-13-00844/article_deploy/html/images/cancers-13-00844-g003.png)